Policy Update: Navigating the DEA’s Geographic Red Flag in Remote Prescribing


This policy update dives into the geographic red flag issue specific to the Drug Enforcement Administration’s (DEA) oversight of remote prescribing of controlled substances. We clarify the issue, outline the key players involved, discuss potential DEA rulemaking as well as its potential impact on state policies, and highlight the urgent stakeholder statement urging the DEA to address this issue.

Our session is designed to unravel the complexities of this challenge, providing participants with a comprehensive understanding of the current situation, the key players involved, and the potential pathways forward


  • Understanding the Issue: Get the answer to what the geographic red flag issue means for remote prescribing.
  • Stakeholders and DEA’s Role: Learn about the stakeholders impacted and how the DEA might address this in future regulations.
  • Implications and Actions: Discover the importance of this issue for the pharmacy community and the urgency of conveying this to the DEA to avoid past mistakes.


  • Libby Lewis Baney – Partner, Faegre Drinker
  • Jessica Rigsby – VP Of Legal And Compliance, Ophelia
  • Kyle Zebley – Senior VP, Public Policy, American Telemedicine Association

Related Resources